EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Germline multigene panel testing in acute and chronic pancreatitis

Mitchell L Ramsey iD, Brandie Heald, Yevgeniya Gokun, Josie Baker, J Royce Groce, Samuel Han, Phil A Hart, Somashekar G Krishna, Luis F Lara, Peter J Lee, Georgios I Papachristou, Rachel Pearlman und 3 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0307076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Mitchell L Ramsey und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America. Hauptthemen laut MEDLINE: Genetic Testing, Pancreatitis, Chronic, Genetic Predisposition to Disease, Germ-Line Mutation. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives Germline genetic testing is recommended for younger patients with idiopathic pancreatitis but there has been a lack of consensus in recommendations for those over age 35. We aimed to analyze the results of genetic testing among subjects of varying ages.

Methods

Individuals who underwent germline multigene testing for pancreatitis susceptibility genes ( CASR , CFTR , CPA1 , CTRC , PRSS1 , SPINK1 ) through a large commercial laboratory between 2017 and 2022 were included. Test results and information collected from test requisition forms were evaluated. Multivariable logistic regression models were performed to identify factors associated with a positive pancreatitis panel (pathogenic, likely pathogenic, and/or increased risk variants) in pancreatitis-related genes.

Results

Overall, 2,468 subjects with primary indication of acute pancreatitis (AP) (n = 401), chronic pancreatitis (CP) (n = 631), pancreatic cancer (n = 128), or other indications (n = 1,308) completed germline testing. Among patients with AP or CP, the prevalence of any positive result for those

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingPancreatitis, ChronicGenetic Predisposition to DiseaseGerm-Line MutationHumansAdultFemaleMaleMiddle AgedAgedPancreatitisYoung AdultAdolescentAcute DiseaseChild

Autor:innen und Institutionen

  • Division of Gastroenterology, Hepatology, and Nutrition, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.
  • Medical Affairs, Invitae Corporation, San Francisco, California, United States of America.
  • Department of Biomedical Informatics, Center for Biostatistics, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.
  • Division of Human Genetics, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.

ORCID-Profile: Mitchell L Ramsey

Zitieren

APA

Ramsey, M. L., Heald, B., Gokun, Y., Baker, J., Groce, J. R., Han, S., Hart, P. A., Krishna, S. G., Lara, L. F., Lee, P. J., Papachristou, G. I., Pearlman, R., Poll, S., Roberts, M. E., & Stanich, P. P. (2024). Germline multigene panel testing in acute and chronic pancreatitis. PLOS ONE. https://doi.org/10.1371/journal.pone.0307076

Vancouver

Ramsey ML, Heald B, Gokun Y, Baker J, Groce JR, Han S, et al. Germline multigene panel testing in acute and chronic pancreatitis. PLOS ONE. 2024. doi:10.1371/journal.pone.0307076

BibTeX
@article{Ramsey2024,
  author = {Ramsey, Mitchell L and Heald, Brandie and Gokun, Yevgeniya and Baker, Josie and Groce, J Royce and Han, Samuel and Hart, Phil A and Krishna, Somashekar G and Lara, Luis F and Lee, Peter J and Papachristou, Georgios I and Pearlman, Rachel and Poll, Sarah and Roberts, Maegan E and Stanich, Peter P},
  title = {Germline multigene panel testing in acute and chronic pancreatitis},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0307076}
}
Kostenlos starten →